DK0509036T3 - Optisk ren R(-)-albuterol til behandling af astma - Google Patents

Optisk ren R(-)-albuterol til behandling af astma

Info

Publication number: DK0509036T3
Authority: DK; Denmark
Prior art keywords: albuterol; asthma; optically pure; treatment; isomer
Prior art date: 1990-01-05

Application number

DK91902520.5T

Other languages

English (en)

Inventor

Timothy J Barberich

James W Young

Original Assignee

Sepracor Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-01-05

Filing date

1991-01-04

Publication date

1996-07-29

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23831837&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0509036(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1991-01-04 Application filed by Sepracor Inc filed Critical Sepracor Inc

1996-07-29 Application granted granted Critical

1996-07-29 Publication of DK0509036T3 publication Critical patent/DK0509036T3/da

Links

208000006673 asthma Diseases 0.000 title abstract 3
NDAUXUAQIAJITI-LBPRGKRZSA-N (R)-salbutamol Chemical compound CC(C)(C)NC[C@H](O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-LBPRGKRZSA-N 0.000 title 1
NDAUXUAQIAJITI-UHFFFAOYSA-N albuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 abstract 3
229960002052 salbutamol Drugs 0.000 abstract 3
229940124630 bronchodilator Drugs 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
230000003389 potentiating effect Effects 0.000 abstract 1
208000024891 symptom Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pulmonology (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DK91902520.5T 1990-01-05 1991-01-04 Optisk ren R(-)-albuterol til behandling af astma DK0509036T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US46126290A	1990-01-05	1990-01-05

Publications (1)

Publication Number	Publication Date
DK0509036T3 true DK0509036T3 (da)	1996-07-29

Family

ID=23831837

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK91902520.5T DK0509036T3 (da)	1990-01-05	1991-01-04	Optisk ren R(-)-albuterol til behandling af astma

Country Status (11)

Country	Link
US (1)	US6083993A (da)
EP (1)	EP0509036B1 (da)
JP (1)	JP3085705B2 (da)
AT (1)	ATE135908T1 (da)
AU (1)	AU7174191A (da)
CA (1)	CA2073181C (da)
DE (1)	DE69118359T2 (da)
DK (1)	DK0509036T3 (da)
ES (1)	ES2085468T3 (da)
GR (1)	GR3020133T3 (da)
WO (1)	WO1991009596A1 (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2289842B (en) *	1991-04-05	1996-01-31	Sepracor Inc	Improved use of ß2 bronchodilator drugs
GB9107196D0 (en) *	1991-04-05	1991-05-22	Sandoz Ag	Improvements in or relating to organic compounds
AU737608B2 (en) *	1997-04-30	2001-08-23	Courage Corporation Pty Ltd	Composition and methods using an eutomer
US6365756B1 (en) *	1998-02-20	2002-04-02	Fine Chemical Corporation Limited	Process for the production of optically enriched (R)- or (S)-albuterol
ZA994264B (en)	1998-07-01	2000-01-25	Warner Lambert Co	Stereoisomers with high affinity for adrenergic receptors.
US7232837B2 (en)	1999-06-29	2007-06-19	Mcneil-Ppc, Inc.	Stereoisomers with high affinity for adrenergic receptors
US20030191151A1 (en) *	2001-10-26	2003-10-09	Imtiaz Chaudry	Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
US20030203930A1 (en) *	2001-10-26	2003-10-30	Imtiaz Chaudry	Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
US6702997B2 (en)	2001-10-26	2004-03-09	Dey, L.P.	Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
JP2003221335A (ja)	2001-10-26	2003-08-05	Dey Lp	慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、システム、キットおよび方法
US20030140920A1 (en) *	2001-10-26	2003-07-31	Dey L.P.	Albuterol inhalation soultion, system, kit and method for relieving symptoms of pediatric asthma
US7378438B2 (en) *	2002-04-19	2008-05-27	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disorders
AU2003278565A1 (en) *	2002-10-25	2004-05-13	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments
US20050020692A1 (en) *	2003-07-24	2005-01-27	Ciofalo Vincent B.	Treatment of heaves
JP2007515402A (ja) *	2003-11-20	2007-06-14	アルターアゴンプロプライエタリーリミテッド	哺乳動物および鳥類の体脂肪および体重の減少方法
WO2005123072A1 (en) *	2004-06-14	2005-12-29	Sepracor Inc.	Methods and compositions for the treatment of pulmonary diseases
AU2005254096A1 (en) *	2004-06-14	2005-12-29	Sepracor Inc.	Methods of using albuterol and calcium activated potassium channel openers
GB0501956D0 (en) *	2005-01-31	2005-03-09	Arrow Internat	Nebulizer formulation
WO2012087094A1 (es) *	2010-12-21	2012-06-28	Techsphere S.A. De C.V.	Composición farmacéutica inhalable para el tratamiento del asma por administración vía aérea mediante un succionador de emulación de aerosol
WO2014108449A1 (en)	2013-01-08	2014-07-17	Atrogi Ab	A screening method, a kit, a method of treatment and a compound for use in a method of treatment
GB201714740D0 (en)	2017-09-13	2017-10-25	Atrogi Ab	New compounds and uses
GB201714745D0 (en)	2017-09-13	2017-10-25	Atrogi Ab	New compounds and uses
GB201714734D0 (en)	2017-09-13	2017-10-25	Atrogi Ab	New compounds and uses
GB201714736D0 (en)	2017-09-13	2017-10-25	Atrogi Ab	New compounds and uses
GB201903832D0 (en)	2019-03-20	2019-05-01	Atrogi Ab	New compounds and methods
GB202205895D0 (en)	2022-04-22	2022-06-08	Atrogi Ab	New medical uses
EP4651867A1 (en)	2023-01-20	2025-11-26	Atrogi AB	Beta 2-adrenergic receptor agonists for treatment or prevention of muscle wasting
GB202302225D0 (en)	2023-02-16	2023-04-05	Atrogi Ab	New medical uses
GB202303229D0 (en)	2023-03-06	2023-04-19	Atrogi Ab	New medical uses
GB202403169D0 (en)	2024-03-05	2024-04-17	Atrogi Ab	New medical uses
WO2025238248A1 (en)	2024-05-17	2025-11-20	Atrogi Ab	USE OF β2-ADRENERGIC RECEPTOR AGONISTS IN TREATING MUSCLE WASTING

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1298494A (en) *	1970-06-17	1972-12-06	Allen & Hanburys Ltd	Phenylethanolamine derivatives
US4965065A (en) *	1986-04-29	1990-10-23	Bristol-Myers Squibb Company	Gastroprotective process and compositions
EP0320550A1 (en) *	1987-12-18	1989-06-21	Bristol-Myers Company	Non steroidal anti-inflammatory drug composition containing H1 blockers, H2 blockers, beta adrenergic agonists or combinations thereof and an alkalizing agent
GB9107196D0 (en) *	1991-04-05	1991-05-22	Sandoz Ag	Improvements in or relating to organic compounds

1991
- 1991-01-04 WO PCT/US1991/000088 patent/WO1991009596A1/en not_active Ceased
- 1991-01-04 JP JP03502985A patent/JP3085705B2/ja not_active Expired - Lifetime
- 1991-01-04 AU AU71741/91A patent/AU7174191A/en not_active Abandoned
- 1991-01-04 DE DE69118359T patent/DE69118359T2/de not_active Expired - Lifetime
- 1991-01-04 EP EP91902520A patent/EP0509036B1/en not_active Expired - Lifetime
- 1991-01-04 AT AT91902520T patent/ATE135908T1/de not_active IP Right Cessation
- 1991-01-04 ES ES91902520T patent/ES2085468T3/es not_active Expired - Lifetime
- 1991-01-04 DK DK91902520.5T patent/DK0509036T3/da active
- 1991-01-04 CA CA002073181A patent/CA2073181C/en not_active Expired - Lifetime
1996
- 1996-05-31 GR GR960401513T patent/GR3020133T3/el unknown
1999
- 1999-12-17 US US09/466,107 patent/US6083993A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP0509036A1 (en)	1992-10-21
JPH05503102A (ja)	1993-05-27
CA2073181A1 (en)	1991-07-06
DE69118359D1 (de)	1996-05-02
WO1991009596A1 (en)	1991-07-11
AU7174191A (en)	1991-07-24
ATE135908T1 (de)	1996-04-15
ES2085468T3 (es)	1996-06-01
JP3085705B2 (ja)	2000-09-11
US6083993A (en)	2000-07-04
GR3020133T3 (en)	1996-08-31
EP0509036B1 (en)	1996-03-27
DE69118359T2 (de)	1996-08-14
CA2073181C (en)	2002-04-23

Similar Documents

Publication	Publication Date	Title
GR3020133T3 (en)	1996-08-31	Optically pure r(-) albuterol for treating asthma
IS4820A (is)	1998-08-10	Aðferð til meðferðar uppsölu og truflana á miðtaugakerfi sem fela í sér notkun norkisapríðs með hreina (+) ljósvirkni
MY105093A (en)	1994-08-30	Process for purifying crude glycerol.
YU37696A (sh)	1999-03-04	Postupak optičkog prečišćavanja jedinjenja
DE68908722D1 (de)	1993-10-07	Dampf-Phasen-Verfahren zur Herstellung eines Diamanten.
FI922434A0 (fi)	1992-05-27	Produktion av rekombinant human interleukin-1-inhibitor.
DK442688A (da)	1988-10-07	Fremgangsmaade og praeparat til behandling af non-ige-medierede lidelser
DE69202307D1 (de)	1995-06-08	Kryogenisches Rektifikationsverfahren zur Herstellung von gereinigtem Argon.
ES2138603T3 (es)	2000-01-16	Procedimiento para el aislamiento de los factores ix, x y ii altamente purificados a partir del complejo protrombinico o del plasma humano.
PT724600E (pt)	2002-07-31	Processo de preparacao de um concentrado de inter-alfa-tripsina inibidor para uso terapeutico e concentrado obtido
PT92148A (pt)	1990-05-31	Processo para a preparacao de pomada contendo colesterol para o tratamento topico de dermatoses
DE69133485D1 (de)	2005-10-20	Verwendung von Staphylococcus Enterotoxin Homologe für Krebs-Therapie
DK0512883T3 (da)	1998-03-16	Fremgangsmåde til fremstilling af et koncentrat af blodkoaguleringsfaktor XI med høj specifik aktivitet, til terapeutisk anvendelse
NO20001343L (no)	2000-03-15	FremgangsmÕter og sammensetninger for behandling av pulmonære forstyrrelser ved anvendelse av optisk ren (S)-salmeterol
IT1242940B (it)	1994-05-18	Impianto ad alto rendimento per la attuazione di emodialisi, emofiltrazione plasmaferesi, emodiafiltrazione
DK0655243T3 (da)	2002-10-07	Melatoninderivater til anvendelse ved behandling af søvnlidelser
FI891473A0 (fi)	1989-03-28	Menetelmä terapeuttisesti käyttökelpoisten 4-aryyli-4-piperidiinikarbinolien valmistamiseksi
AU1438992A (en)	1992-11-17	Water extraction components produced by adhesive bonds, process for their manufacture and their use
DE68907991D1 (de)	1993-09-09	Diamant-diamantbindung.
DK0536564T3 (da)	1998-02-02	Fremgangsmåde til fremstilling af streptolysin O, intakt streptolysin O fremstillet ved denne fremgangsmåde og dets anvendelse
GR74351B (da)	1984-06-26
ES2117197T3 (es)	1998-08-01	Procedimiento para la extraccion y purificacion de alfa1-antitripsina (alfa1-pi) a partir de la fraccion de cohn iv-1.
IT8141606A0 (it)	1981-07-06	Procedimento per la lavorazione delle pelli naturali.
RU93036315A (ru)	1996-04-10	Способ лечения отрубевидного (разноцветного) лишая
BG95867A (bg)	1993-12-24	Метод за обработване на кожи,причиняващи слабо замъгляване